| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling AA Alizadeh, MB Eisen, RE Davis, C Ma, IS Lossos, A Rosenwald, ... Nature 403 (6769), 503-511, 2000 | 12695 | 2000 |
| Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma SS Neelapu, FL Locke, NL Bartlett, LJ Lekakis, DB Miklos, CA Jacobson, ... New England Journal of Medicine 377 (26), 2531-2544, 2017 | 5295 | 2017 |
| Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. P McLaughlin, AJ Grillo-López, BK Link, R Levy, MS Czuczman, ... Journal of clinical oncology 16 (8), 2825-2833, 1998 | 3685 | 1998 |
| Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells FJ Hsu, C Benike, F Fagnoni, TM Liles, D Czerwinski, B Taidi, ... Nature medicine 2 (1), 52-58, 1996 | 2446 | 1996 |
| IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma DG Maloney, AJ Grillo-López, CA White, D Bodkin, RJ Schilder, ... Blood, The Journal of the American Society of Hematology 90 (6), 2188-2195, 1997 | 2287 | 1997 |
| The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy LA Honigberg, AM Smith, M Sirisawad, E Verner, D Loury, B Chang, S Li, ... Proceedings of the National Academy of Sciences 107 (29), 13075-13080, 2010 | 1798 | 2010 |
| Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma WK Weng, R Levy Journal of clinical oncology 21 (21), 3940-3947, 2003 | 1638 | 2003 |
| Two populations of Ia-like molecules on a human B cell line. LA Lampson, R Levy Journal of immunology (Baltimore, Md.: 1950) 125 (1), 293-299, 1980 | 1338 | 1980 |
| Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody RA Miller, DG Maloney, R Warnke, R Levy New England Journal of Medicine 306 (9), 517-522, 1982 | 1300 | 1982 |
| Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial E Abraham, R Wunderink, H Silverman, TM Perl, S Nasraway, H Levy, ... Jama 273 (12), 934-941, 1995 | 1214 | 1995 |
| Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma MP Chao, AA Alizadeh, C Tang, JH Myklebust, B Varghese, S Gill, M Jan, ... Cell 142 (5), 699-713, 2010 | 1206 | 2010 |
| Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes IS Lossos, DK Czerwinski, AA Alizadeh, MA Wechser, R Tibshirani, ... New England Journal of Medicine 350 (18), 1828-1837, 2004 | 1098 | 2004 |
| Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia JW Friedberg, J Sharman, J Sweetenham, PB Johnston, JM Vose, ... Blood, The Journal of the American Society of Hematology 115 (13), 2578-2585, 2010 | 982 | 2010 |
| Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin’s lymphoma: safety and efficacy of re-treatment TA Davis, AJ Grillo-López, CA White, P McLaughlin, MS Czuczman, ... Journal of clinical oncology 18 (17), 3135-3143, 2000 | 873 | 2000 |
| IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. DG Maloney, AJ Grillo-López, DJ Bodkin, CA White, TM Liles, I Royston, ... Journal of clinical oncology 15 (10), 3266-3274, 1997 | 861 | 1997 |
| Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients JM Timmerman, DK Czerwinski, TA Davis, FJ Hsu, C Benike, ZM Hao, ... Blood, The Journal of the American Society of Hematology 99 (5), 1517-1526, 2002 | 762 | 2002 |
| 'Gene shaving'as a method for identifying distinct sets of genes with similar expression patterns T Hastie, R Tibshirani, MB Eisen, A Alizadeh, R Levy, L Staudt, WC Chan, ... Genome biology 1, 1-21, 2000 | 749 | 2000 |
| Dendritic cell vaccines for cancer immunotherapy JM Timmerman, MD, R Levy, MD Annual review of medicine 50 (1), 507-529, 1999 | 714 | 1999 |
| Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors LW Kwak, MJ Campbell, DK Czerwinski, S Hart, RA Miller, R Levy New England Journal of Medicine 327 (17), 1209-1215, 1992 | 693 | 1992 |
| Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma—long-term results of a clinical trial FJ Hsu, CB Caspar, D Czerwinski, LW Kwak, TM Liles, A Syrengelas, ... Blood, The Journal of the American Society of Hematology 89 (9), 3129-3135, 1997 | 606 | 1997 |
